Advanced search
Publication Cover
Journal of Mental Health Volume 29, 2020 - Issue 5
Submit an article Journal homepage
17,798
Views
27
CrossRef citations to date
0
Altmetric
Review Articles

Antipsychotic treatment – a systematic literature review and meta-analysis of qualitative studies

Jone BjornestadDepartment of Social Studies, Faculty of Social Sciences, University of Stavanger, Stavanger, Norway;Correspondence[email protected]
,
Kristina O. LavikDepartment of Psychiatry, District General Hospital of F⊘rde, F⊘rde, Norway;
,
Larry DavidsonSchool of Medicine, Yale University, New Haven, CT, USA;ORCID Iconhttp://orcid.org/0000-0003-1183-8047
ORCID Icon,
Aslak HjeltnesDepartment of Clinical Psychology, University of Bergen, Bergen, Norway
,
Christian MoltuDepartment of Psychiatry, District General Hospital of F⊘rde, F⊘rde, Norway;
&
Marius VesethDepartment of Clinical Psychology, University of Bergen, Bergen, Norway
Pages 513-523 | Received 31 Jul 2018, Accepted 24 Dec 2018, Published online: 12 Mar 2019

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Sara Rhiannon King, Mark Allan & Laura Lindsey. (2022) “I found hundreds of other people…but I still wasn’t believed” – An exploratory study on lived experiences of antipsychotic withdrawal. Psychosis 0:0, pages 1-13.
Read now
Brian Keogh, Esther Murphy, Louise Doyle, Greg Sheaf, Mike Watts & Agnes Higgins. (2022) Mental health service users experiences of medication discontinuation: a systematic review of qualitative studies. Journal of Mental Health 31:2, pages 227-238.
Read now
Kari Standal, Ole Andre Solbakken, Jorun Rugkåsa, Astrid Ringen Martinsen, Margrethe Seeger Halvorsen, Allan Abbass & Kristin Sverdvik Heiervang. (2021) Why Service Users Choose Medication-Free Psychiatric Treatment: A Mixed-Method Study of User Accounts. Patient Preference and Adherence 15, pages 1647-1660.
Read now
Lisa Cosgrove, Zenobia Morrill & Justin M. Karter. (2021) Digital aripiprazole as a human technology. Economy and Society 50:3, pages 359-373.
Read now

Articles from other publishers (23)

Jo Howe, Maura MacPhee, Claire Duddy, Hafsah Habib, Geoff Wong, Simon Jacklin, Sheri Oduola, Rachel Upthegrove, Max Carlish, Katherine Allen, Emma Patterson & Ian Maidment. (2023) A realist review of medication optimisation of community dwelling service users with serious mental illness. BMJ Quality & Safety, pages bmjqs-2023-016615.
Crossref
Julie Perrine Schaug, Ole Jakob Storebø, Marlene Buch Pedersen, Ulrik Helt Haahr & Erik Simonsen. (2023) How first-episode psychosis patients' subjective beliefs about their childhood trauma's causal effect provide support for potential schizophrenia subtypes. Schizophrenia Research 262, pages 175-183.
Crossref
Jorunn Nærland Skjærpe, Wenche ten Velden Hegelstad, Inge Joa & Marianne Storm. (2023) Exploring key determinants of health among individuals with serious mental Illness: qualitative insights from a first episode psychosis cohort, 20 years postdiagnosis. BMC Psychiatry 23:1.
Crossref
Jo Howe & Laura Lindsey. (2023) The role of pharmacists in supporting service users to optimise antipsychotic medication. International Journal of Clinical Pharmacy 45:5, pages 1293-1298.
Crossref
Peter Muris & Thomas H. Ollendick. (2023) Contemporary Hermits: A Developmental Psychopathology Account of Extreme Social Withdrawal (Hikikomori) in Young People. Clinical Child and Family Psychology Review 26:2, pages 459-481.
Crossref
Shanthi Potla, Yousif Al Qabandi, Savitri Aninditha Nandula, Chinmayi Sree Boddepalli, Sai Dheeraj Gutlapalli, Vamsi Krishna Lavu, Rana Abdelwahab Mohamed Abdelwahab, Ruimin Huang & Pousette Hamid. (2023) A Systematic Review of the Need for Guideline Recommendations; Slow Tapering vs. Maintenance Dose in Long-Term Antipsychotic Treatment: 2022. Cureus.
Crossref
Anne Emilie Stürup, Carsten Hjorthøj, Heidi Dorthe Jensen, Marianne Melau, Josefine Winther Davy, Merete Nordentoft & Nikolai Albert. (2023) Self‐reported reasons for discontinuation or continuation of antipsychotic medication in individuals with first‐episode schizophrenia. Early Intervention in Psychiatry.
Crossref
Jan P A M Bogers, George Hambarian, Niels Walburgh Schmidt, Jentien M Vermeulen & Lieuwe de Haan. (2023) Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia. A Meta-Analysis of Randomized Controlled Trials. Schizophrenia Bulletin 49:1, pages 11-23.
Crossref
Ana Lokmer, Charanraj Goud Alladi, Réjane Troudet, Delphine Bacq-Daian, Anne Boland-Auge, Violaine Latapie, Jean-François Deleuze, Ravi Philip RajKumar, Deepak Gopal Shewade, Frank Bélivier, Cynthia Marie-Claire & Stéphane Jamain. (2023) Risperidone response in patients with schizophrenia drives DNA methylation changes in immune and neuronal systems. Epigenomics 15:1, pages 21-38.
Crossref
Nadia E. Crellin, Stefan Priebe, Nicola Morant, Glyn Lewis, Nick Freemantle, Sonia Johnson, Rob Horne, Vanessa Pinfold, Lyn Kent, Ruth Smith, Katherine Darton, Ruth E. Cooper, Maria Long, Jemima Thompson, Lisa Gruenwald, Robert Freudenthal, Jacki L. Stansfeld & Joanna Moncrieff. (2022) An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disorders. BMC Psychiatry 22:1.
Crossref
Gabriela Kattan Khazanov, Shimrit Keddem, Katelin Hoskins, Karoline Myhre, Sarah Sullivan, Emily Mitchell, Brooke Dorsey Holliman, Sara J. Landes & Joseph Simonetti. (2022) Stakeholder perceptions of lethal means safety counseling: A qualitative systematic review. Frontiers in Psychiatry 13.
Crossref
Eman A. Abdel Hameed, Zaitona A. Abd El-Naby, Alaa El Gindy, Sawsan A. Zaitone, Reem Alshaman, Roshdy E. Saraya & Gasser M. Khairy. (2022) Two New HPLC Methods, Assessed by GAPI, for Simultaneous Determination of Four Antipsychotics in Pharmaceutical Formulations: A Comparative Study. Separations 9:8, pages 220.
Crossref
Mariann Iren Vigdal, Christian Moltu, Jone Bjornestad & Lillian Bruland Selseng. (2022) Social recovery in substance use disorder: A metasynthesis of qualitative studies. Drug and Alcohol Review 41:4, pages 974-987.
Crossref
Charmi Patel, Ahong Huang, Li Wang, Yoshita Paliwal & Kruti Joshi. (2022) Patient Journey of Veterans with Schizophrenia: An Analysis of Treatment Patterns, Healthcare Resource Utilization and Costs. Advances in Therapy 39:3, pages 1199-1214.
Crossref
Timothy Wand, Suzanne Glover & Diane Paul. (2021) What should be the future focus of mental health nursing? Exploring the perspectives of mental health nurses, consumers, and allied health staff. International Journal of Mental Health Nursing 31:1, pages 179-188.
Crossref
Samuel J. Millard, Carrie E. Bearden, Katherine H. Karlsgodt & Melissa J. Sharpe. (2021) The prediction-error hypothesis of schizophrenia: new data point to circuit-specific changes in dopamine activity. Neuropsychopharmacology 47:3, pages 628-640.
Crossref
Miriam Boland, Agnes Higgins, Gavin Doherty, Greg Sheaf, Adele Framer & Cathal Cadogan. (2022) Mobile phone applications to support psychotropic tapering: a scoping review protocol. HRB Open Research 5, pages 18.
Crossref
Miriam Boland, Agnes Higgins, Gavin Doherty, Greg Sheaf, Adele Framer & Cathal Cadogan. (2022) Mobile phone applications to support psychotropic tapering: a scoping review protocol. HRB Open Research 5, pages 18.
Crossref
James Tang, Jasmijn Kerklaan, Germaine Wong, Martin Howell, Nicole Scholes-Robertson, Chandana Guha, Ayano Kelly & Allison Tong. (2021) Perspectives of solid organ transplant recipients on medicine-taking: Systematic review of qualitative studies. American Journal of Transplantation 21:10, pages 3369-3387.
Crossref
Parisa Amani, Razieh Habibpour, Leila Karami & Andreas Hofmann. (2021) Docking Screens of Noncovalent Interaction Motifs of the Human Subtype-D2 Receptor–75 Schizophrenia Antipsychotic Complexes with Physicochemical Appraisal of Antipsychotics. ACS Chemical Neuroscience 12:12, pages 2218-2232.
Crossref
Michael Bauer, Tasha Glenn, Martin Alda, Paul Grof, Scott Monteith, Natalie Rasgon, Emanuel Severus & Peter C. Whybrow. (2020) Association between Adherence with an Atypical Antipsychotic and with Other Psychiatric Drugs in Patients with Bipolar Disorder. Pharmacopsychiatry 54:02, pages 75-80.
Crossref
Paul McCrone, Iris Mosweu, Deokhee Yi, Tamatha Ruffell, Bethan Dalton & Til Wykes. (2021) Patient Preferences for Antipsychotic Drug Side Effects: A Discrete Choice Experiment. Schizophrenia Bulletin Open 2:1.
Crossref
Jemima Thompson, Jacki L. Stansfeld, Ruth E. Cooper, Nicola Morant, Nadia E. Crellin & Joanna Moncrieff. (2019) Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: a systematic review and thematic synthesis of qualitative data. Social Psychiatry and Psychiatric Epidemiology 55:2, pages 151-164.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.